PHARMACOTHERAPY OF MYOCARDIAL INFARCTION Dr.S.R.Akshaya navena
Rupture or erosion of local atherosclerotic plaque leading to thrombus formation. Silent infarct or cardiogenic shock. Classified to STEMI – total occlusion by thrombus NSTEMI –partial occlusion by thrombus
MANAGEMENT OF MI RELIEF OF PAIN: Bradycardia – Pethidine hydrochloride (25-50mg). Buprenorphine 0.4mg s.c or 0.3-0.6mg i.m 6-8 hourly. OXYGEN AND REST: 100% oxygen through face mask.
PREVENTION AND TREATMENT OF ARRHYTHMIAS: Prophylactic administration of i.v /oral Beta blocker causes myocardial salvage. Tachyarrhythmais treated with i.v lidocaine,procainamide,amiodarone . Bradycardia managed by atropine or electrical pacing.
BETA BLOCKERS: Given within 4-6hr. Contraindications: Bronchospasm,resting bardycardia (less than 55/min) Low systolic BP(<95mmhg) and heart block. ACEI: Given within 24 hr. Contraindications: Hypotension,bilateral renal artery stenosis,renal failure,history of intolerance.
ANTICOAGULANTS: STEMI,NSTEMI Prevents venous thrombosis,pulmonary embolism,stroke in patients with severe LV dysfunction. LMWH – s.c 3-5days. GENERAL MEASURES: Benzodiazepines,soft low calorie diet,use of stool softeners,life style modifications.
Life long continuation of low dose of Aspirin (75-100mg)-reduce reinfarction . Beta adrenergic blockers: Atenlol,50-100mg od/ Metoprolol 100mg BD fgor 2-3 years. ACE INHIBITORS: Continued in patients with LV dysfunction and in patients with DM. 00 Control of hyperlipidaemia : Dietary substituition with unsaturated fatty acids,statins .